Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2267322

O=C(O)C(F)(F)F.c1ccc(N2CCCC2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
MAPT P10636 6/20 0.58
TSHR P16473 4/20 0.58
HPGD P15428 3/20 0.58
NPC1 O15118 3/20 0.58
TP53 P04637 3/20 0.58
RAB9A P51151 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HSD17B10 Q99714 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
LMNA P02545 2/20 0.58
ALOX15 P16050 1/20 0.58
STAT1 P42224 1/20 0.58
MAPK1 P28482 4/20 0.56
KMT2A Q03164 3/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 2/20 0.51
GAA P10253 1/20 0.51
C1S P09871 1/20 0.49
AKR1C3 P42330 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2160819 0.98 NPC1 (0.56) ALDH1A1MAPTTSHRHPGDNPC1
Phenylpiperazine SCHEMBL3979040 0.84 HTR3E (0.69) ALDH1A1MAPTTSHRTP53HSD17B10
Trifluoroacetic Acid SCHEMBL28476450 0.84 CA12 (0.58) ALDH1A1MAPTTSHRHPGDNPC1
Trifluoroacetic Acid SCHEMBL6986818 0.82 CHKA (0.63) TSHRNPC1RAB9ASMN1; SMN2KMT2A
Oxalic Acid SCHEMBL28160737 0.82 MAPT (0.63) ALDH1A1MAPTTSHRHPGDNPC1
SCHEMBL12485 0.81 L3MBTL1 (0.61) ALDH1A1MAPTTSHRHPGDNPC1
SCHEMBL18228234 0.81 L3MBTL1 (0.61) ALDH1A1MAPTTSHRHPGDNPC1
Urea SCHEMBL27797099 0.80 NPC1 (0.61) ALDH1A1MAPTTSHRHPGDNPC1
Carbamic Acid SCHEMBL27930251 0.80 NPC1 (0.61) ALDH1A1MAPTTSHRHPGDNPC1
Acetic Acid SCHEMBL27760577 0.80 MAPT (0.61) ALDH1A1MAPTTSHRHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201657-A1 AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-08-18 US disclosed
US-20090275619-A1 Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275619-A1 Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors PARP1, PARP3, PARP2 ALDH1A1 325/4885MAPT 51/4885TSHR 2743/4885
US-20110201657-A1 AMIDE SUBSTITUTED INDAZOLE AND BENZOTRIAZOLE DERIVATIVES AS POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS PARP1, PARP3, PARP2 ALDH1A1 325/4885MAPT 51/4885TSHR 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.